Global Anti-tuberculosis Medicine Market Research Report 2022
SKU ID : QYR-21499499 | Publishing Date : 17-Aug-2022
Detailed TOC of Global Anti-tuberculosis Medicine Market Research Report 2022
1 Anti-tuberculosis Medicine Market Overview1.1 Product Overview and Scope of Anti-tuberculosis Medicine
1.2 Anti-tuberculosis Medicine Segment by Type
1.2.1 Global Anti-tuberculosis Medicine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Isoniazid
1.2.3 Rifampin
1.2.4 Ethambutol
1.2.5 Pyrazinamide
1.2.6 Otherr
1.3 Anti-tuberculosis Medicine Segment by Application
1.3.1 Global Anti-tuberculosis Medicine Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals and Clinics
1.3.3 Government Agencies
1.3.4 Non-Profit Organizations
1.3.5 Others
1.4 Global Anti-tuberculosis Medicine Market Size Estimates and Forecasts
1.4.1 Global Anti-tuberculosis Medicine Revenue 2017-2028
1.4.2 Global Anti-tuberculosis Medicine Sales 2017-2028
1.4.3 Anti-tuberculosis Medicine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Anti-tuberculosis Medicine Market Competition by Manufacturers
2.1 Global Anti-tuberculosis Medicine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Anti-tuberculosis Medicine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Anti-tuberculosis Medicine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Anti-tuberculosis Medicine Manufacturing Sites, Area Served, Product Type
2.5 Anti-tuberculosis Medicine Market Competitive Situation and Trends
2.5.1 Anti-tuberculosis Medicine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anti-tuberculosis Medicine Players Market Share by Revenue
2.5.3 Global Anti-tuberculosis Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-tuberculosis Medicine Retrospective Market Scenario by Region
3.1 Global Anti-tuberculosis Medicine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Anti-tuberculosis Medicine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Anti-tuberculosis Medicine Market Facts & Figures by Country
3.3.1 North America Anti-tuberculosis Medicine Sales by Country
3.3.2 North America Anti-tuberculosis Medicine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Anti-tuberculosis Medicine Market Facts & Figures by Country
3.4.1 Europe Anti-tuberculosis Medicine Sales by Country
3.4.2 Europe Anti-tuberculosis Medicine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-tuberculosis Medicine Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-tuberculosis Medicine Sales by Region
3.5.2 Asia Pacific Anti-tuberculosis Medicine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Anti-tuberculosis Medicine Market Facts & Figures by Country
3.6.1 Latin America Anti-tuberculosis Medicine Sales by Country
3.6.2 Latin America Anti-tuberculosis Medicine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anti-tuberculosis Medicine Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-tuberculosis Medicine Sales by Country
3.7.2 Middle East and Africa Anti-tuberculosis Medicine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Anti-tuberculosis Medicine Historic Market Analysis by Type
4.1 Global Anti-tuberculosis Medicine Sales Market Share by Type (2017-2022)
4.2 Global Anti-tuberculosis Medicine Revenue Market Share by Type (2017-2022)
4.3 Global Anti-tuberculosis Medicine Price by Type (2017-2022)
5 Global Anti-tuberculosis Medicine Historic Market Analysis by Application
5.1 Global Anti-tuberculosis Medicine Sales Market Share by Application (2017-2022)
5.2 Global Anti-tuberculosis Medicine Revenue Market Share by Application (2017-2022)
5.3 Global Anti-tuberculosis Medicine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Lupin
6.1.1 Lupin Corporation Information
6.1.2 Lupin Description and Business Overview
6.1.3 Lupin Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Lupin Anti-tuberculosis Medicine Product Portfolio
6.1.5 Lupin Recent Developments/Updates
6.2 Macleods Pharmaceuticals
6.2.1 Macleods Pharmaceuticals Corporation Information
6.2.2 Macleods Pharmaceuticals Description and Business Overview
6.2.3 Macleods Pharmaceuticals Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Macleods Pharmaceuticals Anti-tuberculosis Medicine Product Portfolio
6.2.5 Macleods Pharmaceuticals Recent Developments/Updates
6.3 Otsuka Pharmaceutical
6.3.1 Otsuka Pharmaceutical Corporation Information
6.3.2 Otsuka Pharmaceutical Description and Business Overview
6.3.3 Otsuka Pharmaceutical Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Otsuka Pharmaceutical Anti-tuberculosis Medicine Product Portfolio
6.3.5 Otsuka Pharmaceutical Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Johnson & Johnson Anti-tuberculosis Medicine Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Pfizer Anti-tuberculosis Medicine Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Novartis Anti-tuberculosis Medicine Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Abbott Anti-tuberculosis Medicine Product Portfolio
6.7.5 Abbott Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 AstraZeneca Anti-tuberculosis Medicine Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Corporation Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Bayer Anti-tuberculosis Medicine Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 Eli Lilly
6.10.1 Eli Lilly Corporation Information
6.10.2 Eli Lilly Description and Business Overview
6.10.3 Eli Lilly Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Eli Lilly Anti-tuberculosis Medicine Product Portfolio
6.10.5 Eli Lilly Recent Developments/Updates
6.11 GlaxoSmithKline
6.11.1 GlaxoSmithKline Corporation Information
6.11.2 GlaxoSmithKline Anti-tuberculosis Medicine Description and Business Overview
6.11.3 GlaxoSmithKline Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2017-2022)
6.11.4 GlaxoSmithKline Anti-tuberculosis Medicine Product Portfolio
6.11.5 GlaxoSmithKline Recent Developments/Updates
6.12 Merck
6.12.1 Merck Corporation Information
6.12.2 Merck Anti-tuberculosis Medicine Description and Business Overview
6.12.3 Merck Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Merck Anti-tuberculosis Medicine Product Portfolio
6.12.5 Merck Recent Developments/Updates
6.13 Sanofi
6.13.1 Sanofi Corporation Information
6.13.2 Sanofi Anti-tuberculosis Medicine Description and Business Overview
6.13.3 Sanofi Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Sanofi Anti-tuberculosis Medicine Product Portfolio
6.13.5 Sanofi Recent Developments/Updates
6.14 Chongqing Huapont Pharm
6.14.1 Chongqing Huapont Pharm Corporation Information
6.14.2 Chongqing Huapont Pharm Anti-tuberculosis Medicine Description and Business Overview
6.14.3 Chongqing Huapont Pharm Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Chongqing Huapont Pharm Anti-tuberculosis Medicine Product Portfolio
6.14.5 Chongqing Huapont Pharm Recent Developments/Updates
6.15 Shuangding Pharm
6.15.1 Shuangding Pharm Corporation Information
6.15.2 Shuangding Pharm Anti-tuberculosis Medicine Description and Business Overview
6.15.3 Shuangding Pharm Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Shuangding Pharm Anti-tuberculosis Medicine Product Portfolio
6.15.5 Shuangding Pharm Recent Developments/Updates
6.16 Hongqi pharmaceutical
6.16.1 Hongqi pharmaceutical Corporation Information
6.16.2 Hongqi pharmaceutical Anti-tuberculosis Medicine Description and Business Overview
6.16.3 Hongqi pharmaceutical Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Hongqi pharmaceutical Anti-tuberculosis Medicine Product Portfolio
6.16.5 Hongqi pharmaceutical Recent Developments/Updates
7 Anti-tuberculosis Medicine Manufacturing Cost Analysis
7.1 Anti-tuberculosis Medicine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-tuberculosis Medicine
7.4 Anti-tuberculosis Medicine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-tuberculosis Medicine Distributors List
8.3 Anti-tuberculosis Medicine Customers
9 Anti-tuberculosis Medicine Market Dynamics
9.1 Anti-tuberculosis Medicine Industry Trends
9.2 Anti-tuberculosis Medicine Market Drivers
9.3 Anti-tuberculosis Medicine Market Challenges
9.4 Anti-tuberculosis Medicine Market Restraints
10 Global Market Forecast
10.1 Anti-tuberculosis Medicine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-tuberculosis Medicine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Anti-tuberculosis Medicine by Type (2023-2028)
10.2 Anti-tuberculosis Medicine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-tuberculosis Medicine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Anti-tuberculosis Medicine by Application (2023-2028)
10.3 Anti-tuberculosis Medicine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-tuberculosis Medicine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Anti-tuberculosis Medicine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Anti-tuberculosis Medicine Market Research Report 2022
List of TablesTable 1. Global Anti-tuberculosis Medicine Sales Growth Rate Comparison by Type (2022-2028) & (Kiliton) & (US$ Million)
Table 2. Global Anti-tuberculosis Medicine Sales Growth Rate Comparison by Application (2022-2028) & (Kiliton) & (US$ Million)
Table 3. Global Anti-tuberculosis Medicine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Anti-tuberculosis Medicine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Anti-tuberculosis Medicine Sales (Kiliton) of Key Manufacturers (2017-2022)
Table 6. Global Anti-tuberculosis Medicine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Anti-tuberculosis Medicine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Anti-tuberculosis Medicine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Anti-tuberculosis Medicine Average Price (US$/Ton) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Anti-tuberculosis Medicine Manufacturing Sites and Area Served
Table 11. Manufacturers Anti-tuberculosis Medicine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-tuberculosis Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-tuberculosis Medicine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Anti-tuberculosis Medicine Sales by Region (2017-2022) & (Kiliton)
Table 16. Global Anti-tuberculosis Medicine Sales Market Share by Region (2017-2022)
Table 17. Global Anti-tuberculosis Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Anti-tuberculosis Medicine Revenue Market Share by Region (2017-2022)
Table 19. North America Anti-tuberculosis Medicine Sales by Country (2017-2022) & (Kiliton)
Table 20. North America Anti-tuberculosis Medicine Sales Market Share by Country (2017-2022)
Table 21. North America Anti-tuberculosis Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Anti-tuberculosis Medicine Revenue Market Share by Country (2017-2022)
Table 23. Europe Anti-tuberculosis Medicine Sales by Country (2017-2022) & (Kiliton)
Table 24. Europe Anti-tuberculosis Medicine Sales Market Share by Country (2017-2022)
Table 25. Europe Anti-tuberculosis Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Anti-tuberculosis Medicine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Anti-tuberculosis Medicine Sales by Region (2017-2022) & (Kiliton)
Table 28. Asia Pacific Anti-tuberculosis Medicine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Anti-tuberculosis Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Anti-tuberculosis Medicine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Anti-tuberculosis Medicine Sales by Country (2017-2022) & (Kiliton)
Table 32. Latin America Anti-tuberculosis Medicine Sales Market Share by Country (2017-2022)
Table 33. Latin America Anti-tuberculosis Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Anti-tuberculosis Medicine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Anti-tuberculosis Medicine Sales by Country (2017-2022) & (Kiliton)
Table 36. Middle East and Africa Anti-tuberculosis Medicine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Anti-tuberculosis Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Anti-tuberculosis Medicine Revenue Market Share by Country (2017-2022)
Table 39. Global Anti-tuberculosis Medicine Sales by Type (2017-2022) & (Kiliton)
Table 40. Global Anti-tuberculosis Medicine Sales Market Share by Type (2017-2022)
Table 41. Global Anti-tuberculosis Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Anti-tuberculosis Medicine Revenue Share by Type (2017-2022)
Table 43. Global Anti-tuberculosis Medicine Price by Type (2017-2022) & (US$/Ton)
Table 44. Global Anti-tuberculosis Medicine Sales (Kiliton) by Application (2017-2022)
Table 45. Global Anti-tuberculosis Medicine Sales Market Share by Application (2017-2022)
Table 46. Global Anti-tuberculosis Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Anti-tuberculosis Medicine Revenue Share by Application (2017-2022)
Table 48. Global Anti-tuberculosis Medicine Price by Application (2017-2022) & (US$/Ton)
Table 49. Lupin Corporation Information
Table 50. Lupin Description and Business Overview
Table 51. Lupin Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 52. Lupin Anti-tuberculosis Medicine Product
Table 53. Lupin Recent Developments/Updates
Table 54. Macleods Pharmaceuticals Corporation Information
Table 55. Macleods Pharmaceuticals Description and Business Overview
Table 56. Macleods Pharmaceuticals Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 57. Macleods Pharmaceuticals Anti-tuberculosis Medicine Product
Table 58. Macleods Pharmaceuticals Recent Developments/Updates
Table 59. Otsuka Pharmaceutical Corporation Information
Table 60. Otsuka Pharmaceutical Description and Business Overview
Table 61. Otsuka Pharmaceutical Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 62. Otsuka Pharmaceutical Anti-tuberculosis Medicine Product
Table 63. Otsuka Pharmaceutical Recent Developments/Updates
Table 64. Johnson & Johnson Corporation Information
Table 65. Johnson & Johnson Description and Business Overview
Table 66. Johnson & Johnson Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 67. Johnson & Johnson Anti-tuberculosis Medicine Product
Table 68. Johnson & Johnson Recent Developments/Updates
Table 69. Pfizer Corporation Information
Table 70. Pfizer Description and Business Overview
Table 71. Pfizer Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 72. Pfizer Anti-tuberculosis Medicine Product
Table 73. Pfizer Recent Developments/Updates
Table 74. Novartis Corporation Information
Table 75. Novartis Description and Business Overview
Table 76. Novartis Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 77. Novartis Anti-tuberculosis Medicine Product
Table 78. Novartis Recent Developments/Updates
Table 79. Abbott Corporation Information
Table 80. Abbott Description and Business Overview
Table 81. Abbott Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 82. Abbott Anti-tuberculosis Medicine Product
Table 83. Abbott Recent Developments/Updates
Table 84. AstraZeneca Corporation Information
Table 85. AstraZeneca Description and Business Overview
Table 86. AstraZeneca Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 87. AstraZeneca Anti-tuberculosis Medicine Product
Table 88. AstraZeneca Recent Developments/Updates
Table 89. Bayer Corporation Information
Table 90. Bayer Description and Business Overview
Table 91. Bayer Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 92. Bayer Anti-tuberculosis Medicine Product
Table 93. Bayer Recent Developments/Updates
Table 94. Eli Lilly Corporation Information
Table 95. Eli Lilly Description and Business Overview
Table 96. Eli Lilly Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 97. Eli Lilly Anti-tuberculosis Medicine Product
Table 98. Eli Lilly Recent Developments/Updates
Table 99. GlaxoSmithKline Corporation Information
Table 100. GlaxoSmithKline Description and Business Overview
Table 101. GlaxoSmithKline Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 102. GlaxoSmithKline Anti-tuberculosis Medicine Product
Table 103. GlaxoSmithKline Recent Developments/Updates
Table 104. Merck Corporation Information
Table 105. Merck Description and Business Overview
Table 106. Merck Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 107. Merck Anti-tuberculosis Medicine Product
Table 108. Merck Recent Developments/Updates
Table 109. Sanofi Corporation Information
Table 110. Sanofi Description and Business Overview
Table 111. Sanofi Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 112. Sanofi Anti-tuberculosis Medicine Product
Table 113. Sanofi Recent Developments/Updates
Table 114. Chongqing Huapont Pharm Corporation Information
Table 115. Chongqing Huapont Pharm Description and Business Overview
Table 116. Chongqing Huapont Pharm Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 117. Chongqing Huapont Pharm Anti-tuberculosis Medicine Product
Table 118. Chongqing Huapont Pharm Recent Developments/Updates
Table 119. Shuangding Pharm Corporation Information
Table 120. Shuangding Pharm Description and Business Overview
Table 121. Shuangding Pharm Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 122. Shuangding Pharm Anti-tuberculosis Medicine Product
Table 123. Shuangding Pharm Recent Developments/Updates
Table 124. Hongqi pharmaceutical Corporation Information
Table 125. Hongqi pharmaceutical Description and Business Overview
Table 126. Hongqi pharmaceutical Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 127. Hongqi pharmaceutical Anti-tuberculosis Medicine Product
Table 128. Hongqi pharmaceutical Recent Developments/Updates
Table 129. Production Base and Market Concentration Rate of Raw Material
Table 130. Key Suppliers of Raw Materials
Table 131. Anti-tuberculosis Medicine Distributors List
Table 132. Anti-tuberculosis Medicine Customers List
Table 133. Anti-tuberculosis Medicine Market Trends
Table 134. Anti-tuberculosis Medicine Market Drivers
Table 135. Anti-tuberculosis Medicine Market Challenges
Table 136. Anti-tuberculosis Medicine Market Restraints
Table 137. Global Anti-tuberculosis Medicine Sales Forecast by Type (2023-2028) & (Kiliton)
Table 138. Global Anti-tuberculosis Medicine Sales Market Share Forecast by Type (2023-2028)
Table 139. Global Anti-tuberculosis Medicine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 140. Global Anti-tuberculosis Medicine Revenue Market Share Forecast by Type (2023-2028)
Table 141. Global Anti-tuberculosis Medicine Sales Forecast by Application (2023-2028) & (Kiliton)
Table 142. Global Anti-tuberculosis Medicine Sales Market Share Forecast by Application (2023-2028)
Table 143. Global Anti-tuberculosis Medicine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 144. Global Anti-tuberculosis Medicine Revenue Market Share Forecast by Application (2023-2028)
Table 145. Global Anti-tuberculosis Medicine Sales Forecast by Region (2023-2028) & (Kiliton)
Table 146. Global Anti-tuberculosis Medicine Sales Market Share Forecast by Region (2023-2028)
Table 147. Global Anti-tuberculosis Medicine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 148. Global Anti-tuberculosis Medicine Revenue Market Share Forecast by Region (2023-2028)
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-tuberculosis Medicine
Figure 2. Global Anti-tuberculosis Medicine Market Share by Type in 2021 & 2028
Figure 3. Isoniazid Product Picture
Figure 4. Rifampin Product Picture
Figure 5. Ethambutol Product Picture
Figure 6. Pyrazinamide Product Picture
Figure 7. Otherr Product Picture
Figure 8. Global Anti-tuberculosis Medicine Market Share by Application in 2021 & 2028
Figure 9. Hospitals and Clinics
Figure 10. Government Agencies
Figure 11. Non-Profit Organizations
Figure 12. Others
Figure 13. Global Anti-tuberculosis Medicine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Anti-tuberculosis Medicine Market Size (2017-2028) & (US$ Million)
Figure 15. Global Anti-tuberculosis Medicine Sales (2017-2028) & (Kiliton)
Figure 16. Anti-tuberculosis Medicine Sales Share by Manufacturers in 2021
Figure 17. Global Anti-tuberculosis Medicine Revenue Share by Manufacturers in 2021
Figure 18. The Global 5 and 10 Largest Anti-tuberculosis Medicine Players: Market Share by Revenue in 2021
Figure 19. Anti-tuberculosis Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Anti-tuberculosis Medicine Sales Market Share by Region (2017-2022)
Figure 21. Global Anti-tuberculosis Medicine Sales Market Share by Region in 2021
Figure 22. Global Anti-tuberculosis Medicine Revenue Market Share by Region (2017-2022)
Figure 23. Global Anti-tuberculosis Medicine Revenue Market Share by Region in 2021
Figure 24. United States Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Canada Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Germany Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. France Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. U.K. Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Italy Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Russia Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Japan Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. South Korea Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. India Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Australia Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. China Taiwan Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Indonesia Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Thailand Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Malaysia Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Mexico Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Brazil Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Argentina Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Turkey Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Saudi Arabia Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. UAE Anti-tuberculosis Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Sales Market Share of Anti-tuberculosis Medicine by Type (2017-2022)
Figure 47. Manufacturing Cost Structure of Anti-tuberculosis Medicine
Figure 48. Manufacturing Process Analysis of Anti-tuberculosis Medicine
Figure 49. Anti-tuberculosis Medicine Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Keyplayers in Global Anti-tuberculosis Medicine Market Research Report 2022
LupinMacleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer
Novartis
Abbott
AstraZeneca
Bayer
Eli Lilly
GlaxoSmithKline
Merck
Sanofi
Chongqing Huapont Pharm
Shuangding Pharm
Hongqi pharmaceutical